Momenta and Sandoz appeal

Momenta and Sandoz have filed for an interlocutory, mid-trial appeal against a US court decision that let Amphastar proceed with its antitrust case alleging the two firms “restricted trade and prevented competition in the manufacture and sale of generic enoxaparin”.